CMO of Wolters Kluwer: AI helps with drug diversion
As he describes what's in store for the company in 2024, Dr. Peter Bonis discusses its recent survey on consumer concerns around artificial intelligence and its acquisition of Invistics.
Want to get more stories like this
one? Get daily news updates from Healthcare IT News.
Most Read
Research
White Papers
Patient Engagement
Patient Engagement
Financial/Revenue Cycle Management
Webinars
Artificial Intelligence
